LC-MS/MS is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-05-24. Where a claim depends on a specific study, the study is described rather than over-claimed.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic small-molecule REV-ERB agonist | Not a hormone or natural product |
| Primary targets | REV-ERBα and REV-ERBβ | Nuclear receptors involved in circadian and metabolic regulation |
| Appearance | White to off-white solid | Typical for purified research samples |
| Solubility | Soluble in DMSO and ethanol; low water solubility | Laboratory solubility depends on solvent and purity |
| Common synonyms | SR9009; Stenabolic | Stenabolic is a colloquial name, not a formal chemical name |
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
On October 2, 2025, FIFA announced the video game FIFA Heroes, scheduled for release in 2026 on Android, iOS, Nintendo Switch, PlayStation, and Xbox platforms. In May 2026, the Football Manager 26 video game also announced the addition of licensed 2026 FIFA World Cup content. In December 2025, Netflix announced a new simulation-type game featuring the World Cup, produced by Delphi Interactive and Refactor Games. In May 2026, it was announced the Netflix-published game would be titled FIFA World Cup: Launch Edition; it was released in June 2026. In the same May 2026 announcement, FIFA also confirmed that they would adopt a non-exclusive "Digital Football" ecosystem, with games of various genres adopting the FIFA license. Alongside the new World Cup game were FIFA Heroes, FIFA Rivals, FIFA Super Soccer, Football Manager, eFootball and Rocket League, with more games joining the ecosystem in the following months.
=== Form === Military grade C-4 is commonly packaged as the M112 demolition block. The demolition charge M112 is a rectangular block of Composition C-4 about 2 by 1.5 inches (51 mm × 38 mm) and 11 inches (280 mm) long, weighing 1.25 lb (570 g). The M112 is wrapped in a sometimes olive color Mylar-film container with a pressure-sensitive adhesive tape on one surface. The M112 demolition blocks of C-4 are commonly manufactured into the M183 "demolition charge assembly", which consists of 16 M112 block demolition charges and four priming assemblies packaged inside military Carrying Case M85. The M183 is used to breach obstacles or demolish large structures where larger satchel charges are required. Each priming assembly includes a five-or-twenty-foot (1.5 or 6.1 m) length of detonating cord assembled with detonating cord clips and capped at each end with a booster. When the charge is detonated, the explosive is converted into compressed gas. The gas exerts pressure in the form of a shock wave, which demolishes the target by cutting, breaching, or cratering. Other forms include the mine-clearing line charge and M18A1 Claymore mine.
Baricitinib is a Janus kinase (JAK) inhibitor that reversibly inhibits Janus kinase 1 with a half maximal inhibitory concentration (IC50) of 5.9 nM and Janus kinase 2 with an IC50 of 5.7 nM. Tyrosine kinase 2, which belongs to the same enzyme family, is affected less (IC50 = 53 nM), and Janus kinase 3 far less (IC50 > 400 nM). Via a signal transduction pathway involving STAT proteins, this ultimately modulates gene expression in immunological cells. Other JAK inhibitors include tofacitinib, which is indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis; fedratinib, and ruxolitinib.
== Products == B. animalis is present in many food products and dietary supplements. The probiotic is mostly found in dairy products. Bifidobacterium animalis subsp. lactis BB-12 is a bacterial subspecies within the animalis strain that exhibits rod-shaped structure and lacks catalase activity. The subspecies was initially identified as Bifidobacterium bifidum, however advancements in molecular classification later reclassified it as Bifidobacterium animalis, and subsequently as Bifidobacterium animalis subsp. lactis. It was first preserved in Chr. Hansen's cell culture bank in 1983 as part of the dairy culture collection. It exhibits suitability for producing probiotic dairy products and has found application in infant formula, dietary supplements, and fermented milk products. This is due to a variety of favorable technological characteristics such as its fermentation activity, high tolerance to air, stability, and resilience to acidic and bile environments, even in freeze-dried products. Moreover, Bifidobacterium animalis subsp. lactisBB-12 does not alter the taste, appearance, or texture of food products and maintains viability in probiotic foods until consumption.
=== Generation of pharmaceutical cocrystals === Supercritical fluids act as a new medium for the generation of novel crystalline forms of APIs (Active Pharmaceutical Ingredients) named as pharmaceutical cocrystals. Supercritical fluid technology offers a new platform that allows a single-step generation of particles that are difficult or even impossible to obtain by traditional techniques. The generation of pure and dried new cocrystals (crystalline molecular complexes comprising the API and one or more conformers in the crystal lattice) can be achieved due to unique properties of SCFs by using different supercritical fluid properties: supercritical CO2 solvent power, anti-solvent effect and its atomization enhancement.
Sources: en.wikipedia.org
On 13 December 1904, Hungarian Sándor Just and Croatian Franjo Hanaman were granted a Hungarian patent (No. 34541) for a tungsten filament lamp that lasted longer and gave brighter light than the carbon filament. Tungsten filament lamps were first marketed by the Hungarian company Tungsram in 1904. This type is often called Tungsram-bulbs in many European countries. Filling a bulb with an inert gas such as argon or nitrogen slows the evaporation of the tungsten filament compared to operating it in a vacuum. This allows for greater temperatures and therefore greater efficacy with less reduction in filament life. In 1906, William D. Coolidge developed a method of making "ductile tungsten" from sintered tungsten which could be made into filaments while working for General Electric Company. By 1911 General Electric had begun selling incandescent light bulbs with ductile tungsten wire. In 1913, Irving Langmuir found that filling a lamp with inert gas (nitrogen at first, and later argon) instead of a vacuum resulted in twice the luminous efficacy and reduced bulb blackening. He patented his device on April 18, 1916.
Grand Master Filema Duarte then stripped former Grand Master Urquía Carreño of all his Masonic rights, and referred him to appear in front of the Supreme Court of Masonic Justice, so that they could review the case. On September 10, 2024, Urquía Carreño was then arrested and taken into custody by the National Revolutionary Police at Zanja y Dragones Police Station, the same police station which had launched the theft investigation on January 12. His official charge was the embezzlement of $MN754,410.54 and US$2,700. Urquía Carreño and Airam Cervera were given a travel limit by the Cuban government, prevented from leaving the island with any potential stolen cash. In 2025, Urquía Carreño gave an interview on a YouTube channel associated with the Cuban government in which he denied all wrongdoing, and reiterated his belief that Viñas Alonso was the leader of an anti-government conspiracy alongside Gerardo Cepero and Ángel Santiesteban to remove him from office. He insisted that everything had been orchestrated by this group, beginning with the theft and ending with Urquía Carreño's eventual resignation.
Stop bleeding – to help to seal the wound to expedite the clotting process; Protection from infection – to defend the wound against germs and mechanical damage; Absorb exudate – to soak up blood, plasma, and other fluids exuded from the wound, containing it/them in one place and preventing maceration; Ease pain – either by a medicated analgesic effect, compression or simply preventing pain from further trauma; Debride the wound – to remove slough and foreign objects from the wound to expedite healing; Reduce psychological stress – to obscure a healing wound from the view of the patient and others. Ultimately, the aim of a dressing is to promote healing of the wound by providing a sterile, breathable and moist environment that facilitates granulation and epithelialization. This will then reduce the risk of infection, help the wound heal more quickly, and reduce scarring. Applying, or changing a dressing is a first aid skill, although many people undertake the practice with no training – especially on minor wounds. Modern dressings will almost all come in a prepackaged sterile wrapping, date coded to ensure sterility. Historically, in emergencies and in many less developed regions, dressings are often improvised using available materials such as clothing or spare fabric. These makeshift dressings can serve basic functions like stemming bleeding and absorbing exudate, though, such improvised dressings often need to be used in combination with antiseptic solutions like povidone-iodine to reduce the chances of infection.
== Books == Autobiography Not Bad for a Human – The Life and Films of Lance Henriksen – Lance Henriksen with co-author Joseph Maddrey, published in 2011 by Bloody Pulp Books, featuring art by Bill Sienkiewicz, Mike Mignola, Tom Mandrake, Tim Bradstreet, Eric Powell and Ashley Wood. Comic books To Hell You Ride (five-issue comic book from Dark Horse Comics) (2012) – Lance Henriksen and Joseph Maddrey (co-authors) with Tom Mandrake (artist); a motion-comic video was also made by Dark Horse Comics) (2012) – Lance Henriksen and Joseph Maddrey (co-authors), Tom Mandrake (artist), Lance Henriksen (narrator), TKU: Tecamachalco Underground (Cesar Gallegos/Mateo Latosa) (musical score)
Border tensions continued into the early 2000s, although the two countries cooperated in other areas. The PUP won a landslide victory in the 1998 national elections, and PUP leader Said Musa was sworn in as prime minister. In the 2003 elections the PUP maintained its majority, and Musa continued as prime minister. He pledged to improve conditions in the underdeveloped and largely inaccessible southern part of Belize. In 2005, Belize was the site of unrest caused by discontent with the PUP government, including tax increases in the national budget. On 8 February 2008, Dean Barrow was sworn in as prime minister after his UDP won a landslide victory in general elections. Barrow and the UDP were re-elected in 2012 with a considerably smaller majority. Barrow led the UDP to a third consecutive general election victory in November 2015, increasing the party's number of seats from 17 to 19. He said the election would be his last as party leader and preparations are under way for the party to elect his successor. On 11 November 2020, the People's United Party (PUP), led by Johnny Briceño, defeated the United Democratic Party (UDP) for the first time since 2003, having won 26 seats out of 31 to form the new government of Belize. Briceño took office as prime minister on 12 November. In 2023, Belize became the second Central American country to be awarded certification for the elimination of malaria by the WHO.
Sources: en.wikipedia.org
There are various techniques used in manual therapy for patients with CTS. Some examples include manual and instrumental soft tissue mobilizations, massage therapy, bone mobilizations or manipulations, and neurodynamic techniques, focused on the skeletal system or soft tissue. In cases of epineural tethering in the upper extremity, manual therapy can reduce this dysfunction. It can have a positive impact on the gliding of the nerves through the carpal tunnel while moving the elbow, fingers, or wrist. Manual therapy included the incorporation of specified neurodynamic techniques, functional massage, and carpal bone mobilizations. People who receive physical therapy report less pain and an increased functional ability of their wrists and hands. Self-myofascial ligament stretching has been suggested as an effective technique, although a meta-analysis claimed this form of therapy does not show significant improvement in symptoms or function. However, stretching with a physical therapist can be more beneficial than if the patient stretches alone. Tendon and nerve gliding exercises appear to be useful in carpal tunnel syndrome.
Since the exciton samples many potential analyte binding sites during its excited state lifetime, the probability that the exciton will sample an occupied ‘receptor’ site and be quenched is greatly increased."
== Interactions == No systematic interaction studies with ferric maltol have been conducted. Food reduces its uptake from the gut, as do calcium and magnesium salts and tetracycline antibiotics. Conversely, iron inhibits the uptake of many drugs, such as bisphosphonates, tetracycline antibiotics, quinolone antibiotics, levothyroxin, and levodopa. Combining the drug with intravenous iron can result in fast release of iron into the blood, potentially leading to low blood pressure or even collapse. Dimercaprol in combination with iron is toxic for the kidneys. The antibiotic chloramphenicol interferes with incorporation of iron into red blood cells and with iron excretion. Furthermore, iron can reduce the blood pressure lowering effects of methyldopa. Maltol is metabolized by the enzyme UGT1A6. It is not known whether inhibitors of this enzyme increase maltol concentrations in the body.
Dimethyl fumarate (DMF) is the methyl ester of fumaric acid. Dimethyl fumarate combined with three other fumaric acid esters (FAEs) is solely licensed in Germany as an oral therapy for psoriasis (brand name Fumaderm). Since 2013, it has been approved by the U.S. Food and Drug Administration (FDA) as a treatment option for adults with relapsing multiple sclerosis (brand name Tecfidera). In 2017, an oral formulation of dimethyl fumarate (brand name Skilarence) was approved for medical use in the European Union as a treatment for moderate-to-severe plaque psoriasis. Dimethyl fumarate is thought to have immunomodulatory properties without causing significant immunosuppression. Dimethyl fumarate has also been applied as a biocide in furniture or shoes to prevent growths of mold during storage or transport in humid climates. However, due to cases of allergic reactions after skin contact, dimethyl fumarate-containing consumer products are no longer authorised to be manufactured (since 1998) or imported (since 2009) in the European Union. Dimethyl fumarate is available as a generic medication.
Sources: en.wikipedia.org
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.
It binds REV-ERBα and REV-ERBβ and changes transcription of metabolic genes. This can affect circadian rhythm, lipid use, and mitochondrial function. The full downstream effects are still under study.
No. Some rodent studies show increased endurance, but controlled human trials are lacking. Claims about human performance are not established by published evidence.
SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.